These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38970042)

  • 1. Role of central endpoint adjudication and challenges in trials on neonatal sepsis-a case of ProSPoNS trial.
    Sinha AP; Raja D; Mahajan KS; Sharma P; Gupta SS; Poluru R; Kawade AS; Dayma G; Sazawal S; Bavdekar A; Parida S; Nangia S; Raut AV; Bethou A; Devi P; Gorpade M; Fatima T; Nayak R; Kapil A; Azam M; Khan PA; Pandey RM; Arora NK;
    Trials; 2024 Jul; 25(1):458. PubMed ID: 38970042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the efficacy of a multistrain probiotic supplementation for prevention of neonatal sepsis in 0-2-month-old low birth weight infants in India-the "ProSPoNS" Study protocol for a phase III, multicentric, randomized, double-blind, placebo-controlled trial.
    Sinha AP; Gupta SS; Poluru R; Raut AV; Arora NK; Pandey RM; Sahu AR; Bethou A; Sazawal S; Parida S; Bavdekar A; Saili A; Gaind R; Kapil A; Garg BS; Maliye C; Jain M; Mahajan KS; Dhingra P; Pradhan KC; Kawade AS; Nangia S; Mukherjee A; Rasaily R; Sharma RS;
    Trials; 2021 Apr; 22(1):242. PubMed ID: 33794969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study protocol for economic evaluation of probiotic intervention for prevention of neonatal sepsis in 0-2-month old low-birth weight infants in India: the ProSPoNS trial.
    Sinha A; Bahuguna P; Gupta SS; Kuruba YP; Poluru R; Mathur A; Raja D; Raut AV; Mahajan KS; Sudhakar R; Kulkarni B; Pandey RM; Arora NK; Prinja S
    BMJ Open; 2023 Mar; 13(3):e068215. PubMed ID: 36990484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of efficacy of a 7-day versus a 14-day course of intravenous antibiotics in the treatment of uncomplicated neonatal bacterial sepsis: study protocol of a randomized controlled non-inferiority trial.
    Dutta S; Nangia S; Jajoo M; Gathwala G; Nesargi S; Sundaram M; Kumar P; Saili A; Kumar D; Dalal P; Suman Rao PN; Shanmugam R; Ray P; Randhawa VS; Saigal K; Sharma M; Nagaraj S; Radhakrishnan D
    Trials; 2021 Nov; 22(1):859. PubMed ID: 34844643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of probiotics VSL#3 in prevention of suspected sepsis in low birthweight infants in India: a randomised controlled trial.
    Sinha A; Gupta SS; Chellani H; Maliye C; Kumari V; Arya S; Garg BS; Gaur SD; Gaind R; Deotale V; Taywade M; Prasad MS; Thavraj V; Mukherjee A; Roy M
    BMJ Open; 2015 Jul; 5(7):e006564. PubMed ID: 26163028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community-based antibiotic delivery for possible serious bacterial infections in neonates in low- and middle-income countries.
    Duby J; Lassi ZS; Bhutta ZA
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD007646. PubMed ID: 30970390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons from implementation research on community management of Possible Serious Bacterial Infection (PSBI) in young infants (0-59 days), when the referral is not feasible in Palwal district of Haryana, India.
    Mukhopadhyay R; Arora NK; Sharma PK; Dalpath S; Limbu P; Kataria G; Singh RK; Poluru R; Malik Y; Khera A; Prabhakar PK; Kumar S; Gupta R; Chellani H; Aggarwal KC; Gupta R; Arya S; Aboubaker S; Bahl R; Nisar YB; Qazi SA
    PLoS One; 2021; 16(7):e0252700. PubMed ID: 34234352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enteral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonates.
    Pammi M; Abrams SA
    Cochrane Database Syst Rev; 2019 May; 5(5):CD007138. PubMed ID: 31077334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How long should young infants less than two months of age with moderate-mortality-risk signs of possible serious bacterial infection be hospitalised for? Study protocol for a randomised controlled trial from low- and middle-income countries.
    PSBI Study Group
    J Glob Health; 2023 Jul; 13():04056. PubMed ID: 37448340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants.
    Pammi M; Suresh G
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007137. PubMed ID: 28658720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal probiotic supplementation for prevention of morbidity and mortality in preterm infants.
    Grev J; Berg M; Soll R
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012519. PubMed ID: 30548483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): study protocol for a randomised controlled trial.
    Hill LF; Turner MA; Lutsar I; Heath PT; Hardy P; Linsell L; Jacqz-Aigrain E; Roilides E; Sharland M;
    Trials; 2020 Apr; 21(1):329. PubMed ID: 32293527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal care and community-level treatment seeking for possible severe bacterial infection (PSBI) in Amhara, Ethiopia.
    Asfaha MD; Comeau DL; Spangler SA; Spratt BL; Alamineh L; Gobezayehu AG; Cranmer JN
    BMC Health Serv Res; 2020 Mar; 20(1):264. PubMed ID: 32228682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inositol in preterm infants at risk for or having respiratory distress syndrome.
    Howlett A; Ohlsson A; Plakkal N
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD000366. PubMed ID: 31283839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic regimens for late-onset neonatal sepsis.
    Korang SK; Safi S; Nava C; Greisen G; Gupta M; Lausten-Thomsen U; Jakobsen JC
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013836. PubMed ID: 33998665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protocol for a cluster randomised trial in Madhya Pradesh, India: community health promotion and medical provision and impact on neonates (CHAMPION2); and support to rural India's public education system and impact on numeracy and literacy scores (STRIPES2).
    Agarwal A; Banerji R; Boone P; Elbourne D; Fazzio I; Frost C; Gopal M; Karnati S; Nair R; Reddy H; Reddy P; Sharma D; Shekhawat SS; Shivalli S
    Trials; 2020 Jun; 21(1):569. PubMed ID: 32586400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.